Biosynex (ALBIO) — Capital Reinvestment Ratio
Latest as of December 2024:
2.19x
Biosynex (ALBIO) has a Capital Reinvestment Ratio of 2.19x as of December 2024, meaning it reinvests 2% of its operating cash flow (€1.26 Million) in capital expenditures (€2.77 Million). See Biosynex (ALBIO) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2.19x
Capex / Operating Cash Flow
Operating Cash Flow
€1.26 Million
EUR
Capital Expenditures
€2.77 Million
EUR
Data as of
Dec 2024
Most recent filing
Biosynex Capital Reinvestment Ratio (2009–2022)
This chart tracks Biosynex's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Biosynex (2009–2022)
Year-by-year Capital Reinvestment Ratio for Biosynex from 2009 to 2022. For live market cap and broader valuation context, see Biosynex market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 6.08x | €4.95 Million | €30.08 Million | ▲ +3413.2% |
| 2021 | 0.17x | €109.83 Million | €19.02 Million | ▼ -39.9% |
| 2020 | 0.29x | €31.64 Million | €9.12 Million | ▼ -96.5% |
| 2019 | 8.26x | €1.10 Million | €9.12 Million | ▼ -57.7% |
| 2018 | 19.52x | €467.12K | €9.12 Million | ▲ +3.8% |
| 2017 | 18.81x | €484.82K | €9.12 Million | ▲ +2801.8% |
| 2009 | 0.65x | €72.40K | €46.92K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow